Drug Shortage Report for LEUCOVORIN CALCIUM INJECTION
Report ID | 184317 |
Drug Identification Number | 02087316 |
Brand name | LEUCOVORIN CALCIUM INJECTION |
Common or Proper name | LEUCOVORIN CALCIUM INJECTION |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | LEUCOVORIN |
Strength(s) | 10MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
Packaging size | 1 |
ATC code | V03AF |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2023-02-15 |
Actual start date | |
Estimated end date | 2023-03-15 |
Actual end date | 2023-03-22 |
Shortage status | Resolved |
Updated date | 2023-03-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2023-03-23 | English | Compare |
v5 | 2023-03-22 | French | Compare |
v4 | 2023-03-22 | English | Compare |
v3 | 2023-02-16 | English | Compare |
v2 | 2023-02-10 | French | Compare |
v1 | 2023-02-10 | English | Compare |
Showing 1 to 6 of 6